PRED Predictive Technology Group Inc (CE)

0.0002
0.00 (0.0%)
Last Updated: 20:00:00
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.

Period:

Draw Mode:

Volume 0.00
Bid Price
Ask Price
News -
Day High

Low
0.0001

52 Week Range

High
0.0201

Day Low
Company Name Stock Ticker Symbol Market Type
Predictive Technology Group Inc (CE) PRED OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.0002 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.0002
Trades Volume Avg Volume 52 Week Range
0 0.00 - 0.0001 - 0.0201
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.0002 USD

Predictive Technology Group Inc (CE) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 63.33k 316.67M 35.64M - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Predictive Technology (CE) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No PRED Message Board. Create One! See More Posts on PRED Message Board See More Message Board Posts

Historical PRED Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.00020.00020.00020.00023,0610.000.0%
1 Month0.00020.00030.00020.000246,5630.000.0%
3 Months0.00030.00030.00010.000200943,146-0.0001-33.33%
6 Months0.00030.0010.00010.000241736,344-0.0001-33.33%
1 Year0.00070.02010.00010.000283477,717-0.0005-71.43%
3 Years0.150.670.00010.1354592207,446-0.1498-99.87%
5 Years2.106.910.00011.02304,371-2.10-99.99%

Predictive Technology (CE) Description

Predictive Technology Group, Inc. (Stock Symbol: PRED), a Salt Lake City, UT therapeutics and life sciences company, is a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through unique novel gene-based diagnostics, biotechnology treatments and companion therapeutics. Through its' wholly-owned subsidiaries, Predictive Therapeutics and Predictive Biotech, the company focuses on four main clinical categories: Endometriosis, Scoliosis, Degenerative Disc Disease and Regenerative Human Cell and Tissue Products. In addition to Predictive Biotech's efforts to advance regenerative medicine, Predictive Therapeutics is committed to assisting women in overcoming the devastating consequences of endometriosis via appropriate early-stage diagnosis and subsequent treatment.